Cobram Estate Olives (CBO) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
20 Feb, 2026Executive summary
Underlying EBITDA for the half was AUD 9.5 million, slightly above guidance but down from AUD 14.5 million year-over-year, with net loss after tax widening to AUD 11.9 million due to higher costs and transaction expenses.
Group packaged goods sales were nearly flat at just under AUD 110 million, with flagship brand sales up 7% and growth in both Australia and the USA despite aggressive competitor discounting.
Major capital raise of AUD 177.8 million completed, strengthening the balance sheet and reducing the net debt ratio to 21.7%.
Pending acquisition of California Olive Ranch for US$173.5 million, expected to double U.S. footprint and be EPS accretive from FY 2027, subject to regulatory approval.
Total group sales declined 6.9% to $116.13 million, mainly due to timing and pricing of non-EVOO bulk sales, with most of these sales expected in the second half.
Financial highlights
Australian olive oil business EBITDA was AUD 8.8 million, slightly down year-over-year, with higher net selling prices offset by increased production costs.
USA EBITDA was $0.7 million, down from $2.6 million, due to higher marketing and overhead costs.
Cash flow from operations was AUD 9.9 million, down from AUD 43.6 million, mainly due to higher water and third-party oil purchases and timing of bulk sales.
Net tangible assets per security rose to $1.05 from $0.74 year-over-year.
Available cash and undrawn debt facilities totaled $115.4 million at period end, with total liquidity of $267.6 million including new debt facilities.
Outlook and guidance
Second half expected to be materially stronger, especially in the USA, with higher oil supply and anticipated growth in packaged goods sales.
Australian crop is in an off year but expected to be only moderately lower than last year; FY 2026 EBITDA will be lower than FY 2025.
Packaged goods sales in Australia expected to be broadly in line with last year, with growth in the Cobram Estate brand.
COR acquisition completion expected post antitrust approval, likely after February 2026.
Material fair value gain from the FY26 Australian crop expected in the full-year results.
Latest events from Cobram Estate Olives
- Record profits, U.S.A. expansion, and sustainability drive future growth and shareholder returns.CBO
AGM 20243 Feb 2026 - Record sales and profit growth, with strong outlook and expansion in Australia and the USA.CBO
H2 202423 Jan 2026 - Sales and EBITDA surged, losses narrowed, and U.S. expansion plus a larger crop drive strong outlook.CBO
H1 202523 Dec 2025 - Record profit and sales growth, U.S. expansion, and robust outlook define the year.CBO
H2 202523 Nov 2025 - Record profit, U.S. expansion, and sustainability drive long-term growth and shareholder value.CBO
AGM 202513 Nov 2025 - Major capital raise to fund rapid USA expansion, targeting 3,600 hectares and 9M+ litres of oil.CBO
Investor Presentation9 Sep 2025